Clofibrate and Pexophagy in High-Fat Diet Rats
Author Information
Author(s): Ohshima Kanami, Hara Emika, Takimoto Mio, Bai Yidan, Hirata Mai, Zeng Wen, Uomoto Suzuka, Todoroki Mai, Kobayashi Mio, Kozono Takuma, Kigata Tetsuhito, Shibutani Makoto, Yoshida Toshinori
Primary Institution: Tokyo University of Agriculture and Technology
Hypothesis
Clofibrate induces pexophagy in rats fed a high-fat diet.
Conclusion
Clofibrate effectively reduces steatosis through peroxisome proliferation and pexophagy in high-fat diet-fed rats.
Supporting Evidence
- Clofibrate significantly inhibited HFD-induced steatosis.
- The HFD group showed a 2.4-fold increase in pexophagy receptor NBR1-positive granules.
- Clofibrate increased p62-, LAMP2-, and Pex5-positive granules by 7.5-, 7.2-, and 71.4-fold, respectively.
- The study utilized immunohistochemistry and transmission electron microscopy to analyze liver tissues.
Takeaway
This study shows that a drug called clofibrate helps clean up damaged parts of cells in rats that eat a fatty diet, which can help their livers stay healthy.
Methodology
Rats were divided into four groups and treated with different diets and clofibrate, followed by various analyses including histopathology and gene expression.
Potential Biases
Potential bias in the interpretation of histological and biochemical data.
Limitations
The study was limited to a specific rat model and may not fully represent human conditions.
Participant Demographics
25 male F344/DuCrlCrlj rats, aged 5 weeks.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website